James P. Brady

Ufficiale delle Risorse Umane presso SPERO THERAPEUTICS, INC.

Health Technology

Consumer Services

Profilo

James P.
Brady is currently the Chief Human Resource Officer at Spero Therapeutics, Inc. Prior to his current position, he served as the Vice President-Human Resources at Intarcia Therapeutics, Inc. from 2015 to 2020.
He also held the role of Chief Human Resources Officer at uniQure NV from 2020 to 2021.
Mr. Brady obtained his graduate degree from Harvard University and his undergraduate degree from Marietta College.

Posizioni attive di James P. Brady

Società	Posizione	Inizio
SPERO THERAPEUTICS, INC.	Ufficiale delle Risorse Umane	-

Tutte le posizioni attive di James P. Brady

Precedenti posizioni note di James P. Brady

Società	Posizione	Fine
UNIQURE N.V.	Ufficiale delle Risorse Umane	01/09/2021
Intarcia Therapeutics, Inc. Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.	Ufficiale delle Risorse Umane	01/08/2020

Vedi nel dettaglio l'esperienza di James P. Brady

Formazione di James P. Brady

Marietta College	Undergraduate Degree
Harvard University	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di James P. Brady

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
UNIQURE N.V.	Health Technology
SPERO THERAPEUTICS, INC.	Health Technology

Aziende private	1
Intarcia Therapeutics, Inc. Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.	Health Technology